An Israeli company says it has found a genetic link responsible for as many as one-fifth of all schizophrenia cases. The finding by the Jerusalem-based company IDgene Pharmaceuticals, in collaboration with Hebrew University and Israel’s psychiatric hospitals, will appear in the December issue of The American Journal of Human Genetics.
A Season of Big Decisions. From the Knesset campaign to American midterms, Jewish communities are weighing what comes next. Help JTA keep delivering the deeper context.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.